Breaking News Instant updates and real-time market news.

AVDL

Avadel Pharmaceuticals

$6.02 /

-0.26 (-4.14%)

07:44
08/07/18
08/07
07:44
08/07/18
07:44

Avadel Pharmaceuticals reports Q2 adj. EPS (55c), consensus (31c)

Reports Q2 revenue $29.23M, consensus $28.19M. Reports Q2 GAAP EPS (9c).

  • 07

    Aug

AVDL Avadel Pharmaceuticals
$6.02 /

-0.26 (-4.14%)

03/09/18 Ladenburg
Avadel Pharmaceuticals price target lowered to $24 from $30 at Ladenburg
09/08/17 Roth Capital
Roth Capital 'cautiously optimistic' on Avadel's deal for Noctiva
09/07/17 Ladenburg
Avadel Pharmaceuticals price target raised to $30 from $27 at Ladenburg

TODAY'S FREE FLY STORIES

Earnings
VBL Therapeutics reports Q2 EPS (14c), consensus (14c) » 07:08
08/13/20
08/13
07:08
08/13/20
07:08
VBLT

VBL Therapeutics

$1.31 /

+ (+0.00%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VBLT VBL Therapeutics
$1.31 /

+ (+0.00%)

VBLT VBL Therapeutics
$1.31 /

+ (+0.00%)

11/14/19 Chardan
VBL Therapeutics upgraded to Buy with $3.25 price target at Chardan
11/14/19 Chardan
VBL Therapeutics upgraded to Buy from Neutral at Chardan
VBLT VBL Therapeutics
$1.31 /

+ (+0.00%)

Downgrade
KB Home downgraded to Neutral on construction cost concerns at Seaport Global » 07:07
08/13/20
08/13
07:07
08/13/20
07:07
KBH

KB Home

$36.61 /

+0.62 (+1.72%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KBH KB Home
$36.61 /

+0.62 (+1.72%)

KBH KB Home
$36.61 /

+0.62 (+1.72%)

06:13 Today Seaport Global
KB Home downgraded to Neutral from Buy at Seaport Global
08/11/20 Credit Suisse
KB Home price target raised to $44 from $36 at Credit Suisse
08/06/20 KeyBanc
KB Home upgraded to Overweight at KeyBanc
08/06/20 KeyBanc
KB Home upgraded to Overweight from Sector Weight at KeyBanc
KBH KB Home
$36.61 /

+0.62 (+1.72%)

KBH KB Home
$36.61 /

+0.62 (+1.72%)

KBH KB Home
$36.61 /

+0.62 (+1.72%)

Recommendations
JOYY price target raised to $115 from $86 at Benchmark » 07:07
08/13/20
08/13
07:07
08/13/20
07:07
YY

JOYY

/

+

Benchmark analyst Fawne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
YY JOYY
/

+

YY JOYY
/

+

07/10/20 JPMorgan
JOYY price target raised to 'Street high' $125 at JPMorgan
06/15/20 Credit Suisse
JOYY price target raised to $124 from $88 at Credit Suisse
05/21/20 Benchmark
JOYY price target raised to $86 from $78 at Benchmark
05/20/20 Morgan Stanley
Morgan Stanley upgrades JOYY to Overweight on stepping up monetization of Likee
YY JOYY
/

+

YY JOYY
/

+

YY JOYY
/

+

Upgrade
Conifex Timber upgraded to Outperform from Sector Perform at RBC Capital » 07:07
08/13/20
08/13
07:07
08/13/20
07:07
CFXTF

Conifex Timber

$0.00 /

+ (+0.00%)

RBC Capital analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CFXTF Conifex Timber
$0.00 /

+ (+0.00%)

CFXTF Conifex Timber
$0.00 /

+ (+0.00%)

04/16/20 RBC Capital
Conifex Timber downgraded to Sector Perform from Outperform at RBC Capital
03/12/20 RBC Capital
RBC Capital backs Outperform on Conifex Timber after Q4 results
Earnings
GrowGeneration sees FY21 revenue $245M-$260M, consensus $196.23M » 07:06
08/13/20
08/13
07:06
08/13/20
07:06
GRWG

GrowGeneration

$8.76 /

+0.16 (+1.86%)

Sees adjusted EBITDA for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

07/17/20 Lake Street
GrowGeneration price target raised to $9 from $7 at Lake Street
07/14/20 Oppenheimer
Oppenheimer bullish on GrowGeneration, initiates with an Outperform
07/14/20 Oppenheimer
GrowGeneration initiated with an Outperform at Oppenheimer
07/08/20 Alliance Global Partners
GrowGeneration price target raised to $10 from $8 at Alliance Global Partners
GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

  • 30
    Jun
GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

Hot Stocks
scPharmaceuticals reports Q2 EPS (39c), consensus (42c) » 07:06
08/13/20
08/13
07:06
08/13/20
07:06
SCPH

scPharmaceuticals

$7.94 /

-0.48 (-5.70%)

"The highlight since…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCPH scPharmaceuticals
$7.94 /

-0.48 (-5.70%)

SCPH scPharmaceuticals
$7.94 /

-0.48 (-5.70%)

05/13/20 SVB Leerink
scPharmaceuticals price target raised to $12 from $7 at SVB Leerink
05/13/20 H.C. Wainwright
scPharmaceuticals price target raised to $15 from $13 at H.C. Wainwright
10/15/19 H.C. Wainwright
scPharmaceuticals initiated with a Buy at H.C. Wainwright
SCPH scPharmaceuticals
$7.94 /

-0.48 (-5.70%)

  • 21
    May
SCPH scPharmaceuticals
$7.94 /

-0.48 (-5.70%)

Hot Stocks
Passage Bio expects cash balance to fund operations into 2023 » 07:06
08/13/20
08/13
07:06
08/13/20
07:06
PASG

Passage Bio

$14.82 /

-1.03 (-6.50%)

Cash and cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PASG Passage Bio
$14.82 /

-1.03 (-6.50%)

PASG Passage Bio
$14.82 /

-1.03 (-6.50%)

06/25/20 Goldman Sachs
Passage Bio downgraded to Neutral from Buy at Goldman Sachs
03/25/20
Fly Intel: Top five analyst initiations
03/25/20 Chardan
Passage Bio initiated with a Buy at Chardan
03/24/20
Fly Intel: Top five analyst initiations
PASG Passage Bio
$14.82 /

-1.03 (-6.50%)

  • 28
    Feb
PASG Passage Bio
$14.82 /

-1.03 (-6.50%)

Hot Stocks
Passage Bio announces anticipated upcoming milestones » 07:06
08/13/20
08/13
07:06
08/13/20
07:06
PASG

Passage Bio

$14.82 /

-1.03 (-6.50%)

Initiate a Phase 1/2…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PASG Passage Bio
$14.82 /

-1.03 (-6.50%)

PASG Passage Bio
$14.82 /

-1.03 (-6.50%)

06/25/20 Goldman Sachs
Passage Bio downgraded to Neutral from Buy at Goldman Sachs
03/25/20
Fly Intel: Top five analyst initiations
03/25/20 Chardan
Passage Bio initiated with a Buy at Chardan
03/24/20
Fly Intel: Top five analyst initiations
PASG Passage Bio
$14.82 /

-1.03 (-6.50%)

  • 28
    Feb
PASG Passage Bio
$14.82 /

-1.03 (-6.50%)

Earnings
Leap Therapeutics reports Q2 EPS (12c), consensus (18c) » 07:06
08/13/20
08/13
07:06
08/13/20
07:06
LPTX

Leap Therapeutics

$1.95 /

+0.07 (+3.72%)

Reports Q2 revenue $375K,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LPTX Leap Therapeutics
$1.95 /

+0.07 (+3.72%)

LPTX Leap Therapeutics
$1.95 /

+0.07 (+3.72%)

06/29/20 Piper Sandler
Leap Therapeutics initiated with an Overweight at Piper Sandler
02/10/20 Baird
Leap Therapeutics initiated with an Outperform at Baird
01/08/20 Raymond James
Raymond James upgrades Leap Therapeutics to Outperform on BeiGene deal
01/08/20 Raymond James
Leap Therapeutics upgraded to Outperform from Market Perform at Raymond James
LPTX Leap Therapeutics
$1.95 /

+0.07 (+3.72%)

  • 18
    Jun
LPTX Leap Therapeutics
$1.95 /

+0.07 (+3.72%)

Hot Stocks
Mosaic announces July sales revenue, volumes by business unit » 07:06
08/13/20
08/13
07:06
08/13/20
07:06
MOS

Mosaic

$17.41 /

-0.215 (-1.22%)

Mosaic announced its July…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MOS Mosaic
$17.41 /

-0.215 (-1.22%)

MOS Mosaic
$17.41 /

-0.215 (-1.22%)

08/10/20 Goldman Sachs
Mosaic price target raised to $17 from $14 at Goldman Sachs
07/15/20 Citi
Mosaic upgraded to Buy from Neutral at Citi
06/29/20
Fly Intel: Top five analyst upgrades
06/29/20 BofA
Mosaic upgraded to Buy from Underperform at BofA
MOS Mosaic
$17.41 /

-0.215 (-1.22%)

MOS Mosaic
$17.41 /

-0.215 (-1.22%)

MOS Mosaic
$17.41 /

-0.215 (-1.22%)

Earnings
GrowGeneration sees FY20 revenue $170M-$175M, consensus $143.46M » 07:05
08/13/20
08/13
07:05
08/13/20
07:05
GRWG

GrowGeneration

$8.76 /

+0.16 (+1.86%)

Adjusted EBITDA guidance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

07/17/20 Lake Street
GrowGeneration price target raised to $9 from $7 at Lake Street
07/14/20 Oppenheimer
Oppenheimer bullish on GrowGeneration, initiates with an Outperform
07/14/20 Oppenheimer
GrowGeneration initiated with an Outperform at Oppenheimer
07/08/20 Alliance Global Partners
GrowGeneration price target raised to $10 from $8 at Alliance Global Partners
GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

  • 30
    Jun
GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

Earnings
Passage Bio reports Q2 EPS (60c), consensus (57c) » 07:05
08/13/20
08/13
07:05
08/13/20
07:05
PASG

Passage Bio

$14.82 /

-1.03 (-6.50%)

"We have made…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PASG Passage Bio
$14.82 /

-1.03 (-6.50%)

PASG Passage Bio
$14.82 /

-1.03 (-6.50%)

06/25/20 Goldman Sachs
Passage Bio downgraded to Neutral from Buy at Goldman Sachs
03/25/20
Fly Intel: Top five analyst initiations
03/25/20 Chardan
Passage Bio initiated with a Buy at Chardan
03/24/20
Fly Intel: Top five analyst initiations
PASG Passage Bio
$14.82 /

-1.03 (-6.50%)

  • 28
    Feb
PASG Passage Bio
$14.82 /

-1.03 (-6.50%)

Recommendations
Tencent price target raised to HK$575 from HK$560 at Benchmark » 07:05
08/13/20
08/13
07:05
08/13/20
07:05
TCEHY

Tencent

$0.00 /

+ (+0.00%)

Benchmark analyst Fawne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TCEHY Tencent
$0.00 /

+ (+0.00%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

08/03/20 Morgan Stanley
Sohu.com named a Research Tactical Idea at Morgan Stanley
07/27/20 Barclays
Tencent price target raised to $75 from $63 at Barclays
07/14/20 Citi
Tencent price target raised to HK$649 from HK$541 at Citi
07/08/20 Mizuho
Tencent price target raised to HK$475 from HK$410 at Mizuho
TCEHY Tencent
$0.00 /

+ (+0.00%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

Earnings
GrowGeneration reports Q2 EPS 6c, consensus 5c » 07:05
08/13/20
08/13
07:05
08/13/20
07:05
GRWG

GrowGeneration

$8.76 /

+0.16 (+1.86%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

07/17/20 Lake Street
GrowGeneration price target raised to $9 from $7 at Lake Street
07/14/20 Oppenheimer
Oppenheimer bullish on GrowGeneration, initiates with an Outperform
07/14/20 Oppenheimer
GrowGeneration initiated with an Outperform at Oppenheimer
07/08/20 Alliance Global Partners
GrowGeneration price target raised to $10 from $8 at Alliance Global Partners
GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

  • 30
    Jun
GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

General news
FX Update: The dollar is down for a second day » 07:05
08/13/20
08/13
07:05
08/13/20
07:05

FX Update: The dollar is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Earnings
Brookfield reports Q2 EPS (43c), consensus 39c » 07:04
08/13/20
08/13
07:04
08/13/20
07:04
BAM

Brookfield

$33.82 /

-0.04 (-0.12%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BAM Brookfield
$33.82 /

-0.04 (-0.12%)

BAM Brookfield
$33.82 /

-0.04 (-0.12%)

06/08/20 JPMorgan
Brookfield initiated with an Overweight at JPMorgan
04/08/20 TD Securities
Brookfield upgraded to Action List Buy from Buy at TD Securities
03/29/20 Keefe Bruyette
Brookfield downgraded to Market Perform from Outperform at Keefe Bruyette
03/11/20
Fly Intel: Top five analyst initiations
BAM Brookfield
$33.82 /

-0.04 (-0.12%)

BAM Brookfield
$33.82 /

-0.04 (-0.12%)

BAM Brookfield
$33.82 /

-0.04 (-0.12%)

Hot Stocks
Keros Therapeutics expects cash, cash equivalents to fund operations into 2H22 » 07:04
08/13/20
08/13
07:04
08/13/20
07:04
KROS

Keros Therapeutics

$36.40 /

+0.58 (+1.62%)

Keros' cash and cash…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KROS Keros Therapeutics
$36.40 /

+0.58 (+1.62%)

KROS Keros Therapeutics
$36.40 /

+0.58 (+1.62%)

06/12/20 Piper Sandler
Keros Therapeutics' EHA data bode well for KER-050, says Piper Sandler
05/27/20 Piper Sandler
Keros Therapeutics price target raised to $45 from $35 at Piper Sandler
05/04/20
Fly Intel: Top five analyst initiations
05/04/20 H.C. Wainwright
Keros Therapeutics initiated with a Buy at H.C. Wainwright
KROS Keros Therapeutics
$36.40 /

+0.58 (+1.62%)

  • 08
    Apr
KROS Keros Therapeutics
$36.40 /

+0.58 (+1.62%)

Earnings
Keros Therapeutics reports Q2 EPS (62c), consensus (67c) » 07:04
08/13/20
08/13
07:04
08/13/20
07:04
KROS

Keros Therapeutics

$36.40 /

+0.58 (+1.62%)

Reports Q2 revenue $0,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KROS Keros Therapeutics
$36.40 /

+0.58 (+1.62%)

KROS Keros Therapeutics
$36.40 /

+0.58 (+1.62%)

06/12/20 Piper Sandler
Keros Therapeutics' EHA data bode well for KER-050, says Piper Sandler
05/27/20 Piper Sandler
Keros Therapeutics price target raised to $45 from $35 at Piper Sandler
05/04/20
Fly Intel: Top five analyst initiations
05/04/20 H.C. Wainwright
Keros Therapeutics initiated with a Buy at H.C. Wainwright
KROS Keros Therapeutics
$36.40 /

+0.58 (+1.62%)

  • 08
    Apr
KROS Keros Therapeutics
$36.40 /

+0.58 (+1.62%)

Initiation
Truist starts TCR2 Therapeutics at Buy with $40 price target » 07:03
08/13/20
08/13
07:03
08/13/20
07:03
TCRR

TCR2 Therapeutics

$16.76 /

-0.09 (-0.53%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TCRR TCR2 Therapeutics
$16.76 /

-0.09 (-0.53%)

TCRR TCR2 Therapeutics
$16.76 /

-0.09 (-0.53%)

08/12/20 Truist
TCR2 Therapeutics initiated with a Buy at Truist
08/12/20 Piper Sandler
TCR2 Therapeutics initiated with an Overweight at Piper Sandler
07/27/20 H.C. Wainwright
TCR2 Therapeutics price target raised to $33 from $19 at H.C. Wainwright
07/27/20 Roth Capital
TCR2 Therapeutics upgraded to Buy from Neutral at Roth Capital
TCRR TCR2 Therapeutics
$16.76 /

-0.09 (-0.53%)

  • 29
    Jul
Earnings
Fly Leasing reports Q2 adjusted EPS 37c, consensus 45c » 07:03
08/13/20
08/13
07:03
08/13/20
07:03
FLY

Fly Leasing

$9.26 /

+0.665 (+7.74%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FLY Fly Leasing
$9.26 /

+0.665 (+7.74%)

FLY Fly Leasing
$9.26 /

+0.665 (+7.74%)

05/26/20 JPMorgan
JPMorgan upgrades Fly Leasing with stock rally lagging peers
05/26/20 JPMorgan
Fly Leasing upgraded to Overweight from Neutral at JPMorgan
05/11/20 Deutsche Bank
Fly Leasing price target lowered to $10 from $20 at Deutsche Bank
10/21/19 JPMorgan
Fly Leasing upgraded to Neutral following underperformance at JPMorgan
FLY Fly Leasing
$9.26 /

+0.665 (+7.74%)

Upgrade
KAR Auction upgraded to Buy from Neutral at Northcoast » 07:02
08/13/20
08/13
07:02
08/13/20
07:02
KAR

KAR Auction

$17.85 /

+0.805 (+4.72%)

Northcoast analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KAR KAR Auction
$17.85 /

+0.805 (+4.72%)

KAR KAR Auction
$17.85 /

+0.805 (+4.72%)

06/17/20 SunTrust
KAR Auction price target raised to $20 from $15 at SunTrust
05/08/20 JPMorgan
KAR Auction will become 'defensive auto stock,' says JPMorgan
04/23/20 JPMorgan
KAR Auction upgraded to Overweight on end-market resiliency at JPMorgan
04/23/20 JPMorgan
KAR Auction upgraded to Overweight from Neutral at JPMorgan
KAR KAR Auction
$17.85 /

+0.805 (+4.72%)

Hot Stocks
Precision BioSciences says cash, cash equivalents to fund operations into 2022 » 07:02
08/13/20
08/13
07:02
08/13/20
07:02
DTIL

Precision BioSciences

$6.67 /

-0.08 (-1.19%)

As of June 30, 2020,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DTIL Precision BioSciences
$6.67 /

-0.08 (-1.19%)

DTIL Precision BioSciences
$6.67 /

-0.08 (-1.19%)

07/27/20 BTIG
Precision BioSciences assumed with a Buy at BTIG
05/18/20 H.C. Wainwright
Precision BioSciences could have 'significant upside,' says H.C. Wainwright
04/02/20 Goldman Sachs
Precision BioSciences downgraded to Neutral from Buy at Goldman Sachs
04/02/20 Goldman Sachs
Precision BioSciences downgraded to Neutral from Buy at Goldman Sachs
DTIL Precision BioSciences
$6.67 /

-0.08 (-1.19%)

DTIL Precision BioSciences
$6.67 /

-0.08 (-1.19%)

Earnings
Precision BioSciences reports Q2 EPS (63c), consensus (59c) » 07:02
08/13/20
08/13
07:02
08/13/20
07:02
DTIL

Precision BioSciences

$6.67 /

-0.08 (-1.19%)

Reports Q2 revenue $1.1M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DTIL Precision BioSciences
$6.67 /

-0.08 (-1.19%)

DTIL Precision BioSciences
$6.67 /

-0.08 (-1.19%)

07/27/20 BTIG
Precision BioSciences assumed with a Buy at BTIG
05/18/20 H.C. Wainwright
Precision BioSciences could have 'significant upside,' says H.C. Wainwright
04/02/20 Goldman Sachs
Precision BioSciences downgraded to Neutral from Buy at Goldman Sachs
04/02/20 Goldman Sachs
Precision BioSciences downgraded to Neutral from Buy at Goldman Sachs
DTIL Precision BioSciences
$6.67 /

-0.08 (-1.19%)

DTIL Precision BioSciences
$6.67 /

-0.08 (-1.19%)

Downgrade
Solaris Oilfield downgraded to Equal Weight from Overweight at Wells Fargo » 07:01
08/13/20
08/13
07:01
08/13/20
07:01
SOI

Solaris Oilfield

$8.21 /

+0.155 (+1.93%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SOI Solaris Oilfield
$8.21 /

+0.155 (+1.93%)

SOI Solaris Oilfield
$8.21 /

+0.155 (+1.93%)

05/04/20 Imperial Capital
Solaris Oilfield price target raised to $9 from $7 at Imperial Capital
04/15/20 Piper Sandler
Solaris Oilfield downgraded to Neutral from Overweight at Piper Sandler
04/14/20 Piper Sandler
Solaris Oilfield downgraded to Neutral from Overweight at Piper Sandler
04/13/20 Imperial Capital
Solaris Oilfield price target lowered to $7 from $16 at Imperial Capital
SOI Solaris Oilfield
$8.21 /

+0.155 (+1.93%)

Upgrade
Schlumberger upgraded to Overweight from Equal Weight at Wells Fargo » 07:00
08/13/20
08/13
07:00
08/13/20
07:00
SLB

Schlumberger

$20.35 /

+0.04 (+0.20%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SLB Schlumberger
$20.35 /

+0.04 (+0.20%)

SLB Schlumberger
$20.35 /

+0.04 (+0.20%)

07/27/20 Citi
Schlumberger upgraded to Buy from Neutral at Citi
07/16/20 Scotiabank
Schlumberger upgraded to Outperform from Sector Perform at Scotiabank
07/15/20 Cowen
Schlumberger upgraded to Outperform from Market Perform at Cowen
07/15/20 Cowen
Schlumberger upgraded to Outperform from Market Perform at Cowen
SLB Schlumberger
$20.35 /

+0.04 (+0.20%)

SLB Schlumberger
$20.35 /

+0.04 (+0.20%)

SLB Schlumberger
$20.35 /

+0.04 (+0.20%)

SLB Schlumberger
$20.35 /

+0.04 (+0.20%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.